"platinum resistant" ovarian cancer: What is it, who to treat and how to measure benefit?

Alison Davis*, Anna V. Tinker, Michael Friedlander

*Corresponding author for this work

    Research output: Contribution to journalReview articlepeer-review

    365 Citations (Scopus)

    Fingerprint

    Dive into the research topics of '"platinum resistant" ovarian cancer: What is it, who to treat and how to measure benefit?'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science

    Medicine and Dentistry